Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Inventory (2016 - 2025)

STRATA Skin Sciences' Inventory history spans 14 years, with the latest figure at $3.1 million for Q3 2025.

  • For Q3 2025, Inventory rose 11.44% year-over-year to $3.1 million; the TTM value through Sep 2025 reached $3.1 million, up 11.44%, while the annual FY2024 figure was $2.2 million, 15.97% down from the prior year.
  • Inventory for Q3 2025 was $3.1 million at STRATA Skin Sciences, down from $3.2 million in the prior quarter.
  • Across five years, Inventory topped out at $6.1 million in Q3 2023 and bottomed at $2.2 million in Q4 2024.
  • The 5-year median for Inventory is $3.2 million (2021), against an average of $3.7 million.
  • The largest annual shift saw Inventory skyrocketed 75.57% in 2022 before it crashed 55.2% in 2024.
  • A 5-year view of Inventory shows it stood at $3.5 million in 2021, then decreased by 11.29% to $3.1 million in 2022, then fell by 13.63% to $2.7 million in 2023, then dropped by 15.97% to $2.2 million in 2024, then skyrocketed by 36.15% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Inventory are $3.1 million (Q3 2025), $3.2 million (Q2 2025), and $2.7 million (Q1 2025).